Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Radioimmunotherapy: How Strong an Option Is It?Radioimmunotherapy: How Strong an Option Is It?
Link ID 38932
Title Radioimmunotherapy: How Strong an Option Is It?Radioimmunotherapy: How Strong an Option Is It?
Url http://www.medscape.com/viewarticle/757066?src=rsshttp://www.medscape.com/viewarticle/757066?src=rss
Description Dr. Bruce Cheson reviews recent and older studies to assess how strong a treatment option radioimmunotherapy is for patients with follicular lymphoma. Medscape Hematology-Oncology
Category Articles > Hematology-Oncology
Keywords
Date Jan 21, 2012
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. American Society for Radiation Oncology (ASTRO) 53rd Annual MeetingAmerican Society for Radiation On
  Read clinically focused news coverage of key developments from the meeting. Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


2. Robert Weinberg Rewarded for Oncogene Discovery
  Robert A. Weinberg, PhD, who discovered the first human oncogene, will receive the 2011 ASCO Science of Oncology Award at the annual meeting in June. Medscape Medical News
Category:   Articles > Hematology-Oncology


3. Rituximab Plus Chemotherapy for Untreated CLL: "Highly Effective"
  Rituximab immunotherapy combined with fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) is a highly effective regimen for previously untreated chronic lymphocytic leukemia (CLL), new research shows. Reuters Health Information
Category:   Articles > Hematology-Oncology


4. FDA Approves Pazopanib for Advanced Soft Tissue SarcomaFDA Approves Pazopanib for Advanced Soft Tiss
  The tyrosine kinase inhibitor pazopanib has received approval for the treatment of advanced soft tissue sarcoma in previously treated patients. FDA Approvals
Category:   Articles > Hematology-Oncology


5. Monitoring of Magnetic Targeting to Tumor Vasculature Through MRI and Biodistribution
  A promising new cancer drug delivery system utilizes magnetic cationic liposomes, which can be guided to the tumor site by external magnet and monitored noninvasively with MRI. Nanomedicine
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS